{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:20:55Z","timestamp":1793924455083,"version":"4.8.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1007\/s40257-018-00416-4","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T22:03:41Z","timestamp":1547676221000},"page":"217-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?"],"prefix":"10.1007","volume":"20","author":[{"given":"Sylvia Aide","family":"Mart\u00ednez-Cabriales","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Rodr\u00edguez-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil H.","family":"Shear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"issue":"1","key":"416_CR1","first-page":"23","volume":"113","author":"PC Newbold","year":"1970","unstructured":"Newbold PC. Drug eruptions. Calif Med. 1970;113(1):23\u201331.","journal-title":"Calif Med."},{"issue":"5","key":"416_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/archinte.1948.00220230003001","volume":"81","author":"JJ Van Wyk","year":"1948","unstructured":"Van Wyk JJ, Hoffmann CR. Periarteritis nodosa; a case of fatal exfoliative dermatitis resulting from dilantin sodium sensitization. Arch Intern Med. 1948;81(5):605\u201311.","journal-title":"Arch Intern Med"},{"issue":"23","key":"416_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM195006082422304","volume":"242","author":"BH Chaiken","year":"1950","unstructured":"Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med. 1950;242(23):897\u20138. https:\/\/doi.org\/10.1056\/nejm195006082422304.","journal-title":"N Engl J Med"},{"issue":"11","key":"416_CR4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1212\/WNL.29.11.1480","volume":"29","author":"F Haruda","year":"1979","unstructured":"Haruda F. Phenytoin hypersensitivity: 38 cases. Neurology. 1979;29(11):1480\u20135.","journal-title":"Neurology."},{"issue":"5","key":"416_CR5","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/0002-9343(53)90376-3","volume":"14","author":"TE McGeachy","year":"1953","unstructured":"McGeachy TE, Bloomer WE. The phenobarbital sensitivity syndrome. Am J Med. 1953;14(5):600\u20134.","journal-title":"Am J Med"},{"issue":"1","key":"416_CR6","first-page":"68","volume":"52","author":"WJ McCormick","year":"1945","unstructured":"McCormick WJ. Sulfonamide sensitivity and C-avitaminosis. Can Med Assoc J. 1945;52(1):68\u201370.","journal-title":"Can Med Assoc J"},{"issue":"4","key":"416_CR7","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/j.1365-2230.1984.tb00828.x","volume":"9","author":"D Shuttleworth","year":"1984","unstructured":"Shuttleworth D, Graham-Brown RA, Williams AJ, Campbell AC, Sewell H. Pseudo-lymphoma associated with carbamazepine. Clin Exp Dermatol. 1984;9(4):421\u20133.","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"416_CR8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/0003-4819-28-1-181","volume":"28","author":"MJ Goodman","year":"1948","unstructured":"Goodman MJ. Periarteritis nodosa with recovery; report of an unusual case apparently due to sensitivity to sulfadiazine. Ann Intern Med. 1948;28(1):181\u20137.","journal-title":"Ann Intern Med"},{"issue":"10","key":"416_CR9","first-page":"1377","volume":"36","author":"DB Haughey","year":"1979","unstructured":"Haughey DB, Lanse S, Imhoff T, Tobin M, Schentag JJ. Allopurinol sensitivity: report of two cases. Am J Hosp Pharm. 1979;36(10):1377\u201380.","journal-title":"Am J Hosp Pharm."},{"issue":"7","key":"416_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/00006454-198807000-00022","volume":"7","author":"RA Hicks","year":"1988","unstructured":"Hicks RA, Murphy JV, Jackson MA. Kawasaki-like syndrome caused by carbamazepine. Pediatr Infect Dis J. 1988;7(7):525\u20136.","journal-title":"Pediatr Infect Dis J."},{"issue":"13","key":"416_CR11","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJM198109243051302","volume":"305","author":"SP Spielberg","year":"1981","unstructured":"Spielberg SP, Gordon GB, Blake DA, Goldstein DA, Herlong HF. Predisposition to phenytoin hepatotoxicity assessed in vitro. N Engl J Med. 1981;305(13):722\u20137. https:\/\/doi.org\/10.1056\/nejm198109243051302.","journal-title":"N Engl J Med"},{"issue":"9","key":"416_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1001\/archderm.1978.01640210045013","volume":"114","author":"J Stanley","year":"1978","unstructured":"Stanley J, Fallon-Pellicci V. Phenytoin hypersensitivity reaction. Arch Dermatol. 1978;114(9):1350\u20133.","journal-title":"Arch Dermatol"},{"key":"416_CR13","doi-asserted-by":"publisher","unstructured":"Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk. J Clin Invest. 1988;82(6):1826\u201332. https:\/\/doi.org\/10.1172\/jci113798.","DOI":"10.1172\/jci113798"},{"issue":"11","key":"416_CR14","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1139\/y85-225","volume":"63","author":"NH Shear","year":"1985","unstructured":"Shear NH, Spielberg SP. In vitro evaluation of a toxic metabolite of sulfadiazine. Can J Physiol Pharmacol. 1985;63(11):1370\u20132.","journal-title":"Can J Physiol Pharmacol"},{"issue":"Suppl 28","key":"416_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2133.1985.tb15637.x","volume":"113","author":"NH Shear","year":"1985","unstructured":"Shear NH, Spielberg SP. An in vitro lymphocytotoxicity assay for studying adverse reactions to sulphonamides. Br J Dermatol. 1985;113(Suppl 28):112\u20133.","journal-title":"Br J Dermatol"},{"issue":"2","key":"416_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1525-1470.1983.tb01109.x","volume":"1","author":"NH Shear","year":"1983","unstructured":"Shear NH, Spielberg SP. Pharmacogenetics and adverse drug reactions in the skin. Pediatr Dermatol. 1983;1(2):165\u201373.","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"416_CR17","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","volume":"15","author":"H Bocquet","year":"1996","unstructured":"Bocquet H, Bagot M, Roujeau JC. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg. 1996;15(4):250\u20137.","journal-title":"Semin Cutan Med Surg"},{"issue":"7","key":"416_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/archderm.134.7.874","volume":"134","author":"RD Sontheimer","year":"1998","unstructured":"Sontheimer RD, Houpt KR. DIDMOHS: a proposed consensus nomenclature for the drug-induced delayed multiorgan hypersensitivity syndrome. Arch Dermatol. 1998;134(7):874\u20136.","journal-title":"Arch Dermatol"},{"issue":"4","key":"416_CR19","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1365-2133.1997.tb03795.x","volume":"137","author":"V Descamps","year":"1997","unstructured":"Descamps V, Bouscarat F, Laglenne S, Aslangul E, Veber B, Descamps D, et al. Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive haemophagocytic syndrome. Br J Dermatol. 1997;137(4):605\u20138.","journal-title":"Br J Dermatol"},{"issue":"9","key":"416_CR20","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1001\/archderm.134.9.1113","volume":"134","author":"M Tohyama","year":"1998","unstructured":"Tohyama M, Yahata Y, Yasukawa M, Inagi R, Urano Y, Yamanishi K, et al. Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6. Arch Dermatol. 1998;134(9):1113\u20137.","journal-title":"Arch Dermatol"},{"issue":"9","key":"416_CR21","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","volume":"134","author":"Y Suzuki","year":"1998","unstructured":"Suzuki Y, Inagi R, Aono T, Yamanishi K, Shiohara T. Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome. Arch Dermatol. 1998;134(9):1108\u201312.","journal-title":"Arch Dermatol"},{"key":"416_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000335624","volume":"97","author":"T Shiohara","year":"2012","unstructured":"Shiohara T, Kano Y, Takahashi R, Ishida T, Mizukawa Y. Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Chem Immunol Allergy. 2012;97:122\u201338. https:\/\/doi.org\/10.1159\/000335624.","journal-title":"Chem Immunol Allergy"},{"key":"416_CR23","volume-title":"The 11th revision of the International Classification of Diseases (ICD)","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. The 11th revision of the International Classification of Diseases (ICD). Geneva: World Health Organization; 2018."},{"key":"416_CR24","volume-title":"The 10th revision of the International Classification of Diseases (ICD)","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. The 10th revision of the International Classification of Diseases (ICD). Geneva: World Health Organization; 2015."},{"issue":"6","key":"416_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1586\/edm.12.45","volume":"7","author":"T Shiohara","year":"2012","unstructured":"Shiohara T, Kano Y. Drug-induced hypersensitivity syndrome: recent advances in drug allergy. Expert Rev Dermatol. 2012;7(6):539\u201347.","journal-title":"Expert Rev Dermatol."},{"issue":"2","key":"416_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/14740338.2017.1270940","volume":"16","author":"T Shiohara","year":"2017","unstructured":"Shiohara T, Kano Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management. Expert Opin Drug Saf. 2017;16(2):139\u201347. https:\/\/doi.org\/10.1080\/14740338.2017.1270940.","journal-title":"Expert Opin Drug Saf."},{"key":"416_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000104205","volume-title":"Drug hypersensitivity","author":"T Shiohara","year":"2007","unstructured":"Shiohara T, Takahashi R, Kano Y. Drug-induced hypersensitivity syndrome and viral reactivation. In: Pichler WJ, editor. Drug hypersensitivity. Basel: Karger; 2007. p. 251\u201366."},{"issue":"12","key":"416_CR28","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","volume":"146","author":"YC Chen","year":"2010","unstructured":"Chen YC, Chiu HC, Chu CY. Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases. Arch Dermatol. 2010;146(12):1373\u20139. https:\/\/doi.org\/10.1001\/archdermatol.2010.198.","journal-title":"Arch Dermatol"},{"key":"416_CR29","doi-asserted-by":"publisher","unstructured":"Kardaun SH, Sekula P, Valeyrie-Allanore L, Liss Y, Chu CY, Creamer D, et al.; RegiSCAR study group. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013;169(5):1071\u201380. https:\/\/doi.org\/10.1111\/bjd.12501.","DOI":"10.1111\/bjd.12501"},{"key":"416_CR30","doi-asserted-by":"publisher","unstructured":"Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18061243.","DOI":"10.3390\/ijms18061243"},{"issue":"9308","key":"416_CR31","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","volume":"359","author":"S Mallal","year":"2002","unstructured":"Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet. 2002;359(9308):727\u201332.","journal-title":"Lancet"},{"issue":"12","key":"416_CR32","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1056\/NEJMoa1013297","volume":"364","author":"M McCormack","year":"2011","unstructured":"McCormack M, Alfirevic A, Bourgeois S, Farrell JJ, Kasperaviciute D, Carrington M, et al. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans. N Engl J Med. 2011;364(12):1134\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1013297.","journal-title":"N Engl J Med"},{"issue":"4","key":"416_CR33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","volume":"16","author":"SI Hung","year":"2006","unstructured":"Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenet Genomics. 2006;16(4):297\u2013306. https:\/\/doi.org\/10.1097\/01.fpc.0000199500.46842.4a.","journal-title":"Pharmacogenet Genomics"},{"issue":"1\u20132","key":"416_CR34","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","volume":"97","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee KW, Song WJ, Kim SH, Jee YK, Lee SM, et al. Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res. 2011;97(1\u20132):190\u20137. https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.08.010.","journal-title":"Epilepsy Res"},{"issue":"5","key":"416_CR35","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/hmg\/ddq537","volume":"20","author":"T Ozeki","year":"2011","unstructured":"Ozeki T, Mushiroda T, Yowang A, Takahashi A, Kubo M, Shirakata Y, et al. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population. Hum Mol Genet. 2011;20(5):1034\u201341. https:\/\/doi.org\/10.1093\/hmg\/ddq537.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"416_CR36","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/clpt.2012.189","volume":"92","author":"VL Yip","year":"2012","unstructured":"Yip VL, Marson AG, Jorgensen AL, Pirmohamed M, Alfirevic A. HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review. Clin Pharmacol Ther. 2012;92(6):757\u201365. https:\/\/doi.org\/10.1038\/clpt.2012.189.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"416_CR37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.2217\/pgs.11.165","volume":"13","author":"M McCormack","year":"2012","unstructured":"McCormack M, Urban TJ, Shianna KV, Walley N, Pandolfo M, Depondt C, et al. Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions. Pharmacogenomics. 2012;13(4):399\u2013405. https:\/\/doi.org\/10.2217\/pgs.11.165.","journal-title":"Pharmacogenomics."},{"issue":"3","key":"416_CR38","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/bjd.12389","volume":"169","author":"M Goncalo","year":"2013","unstructured":"Goncalo M, Coutinho I, Teixeira V, Gameiro AR, Brites MM, Nunes R, et al. HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome\/toxic epidermal necrolysis in a Portuguese population. Br J Dermatol. 2013;169(3):660\u20135. https:\/\/doi.org\/10.1111\/bjd.12389.","journal-title":"Br J Dermatol"},{"issue":"11","key":"416_CR39","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA. 2005;102(11):4134\u20139. https:\/\/doi.org\/10.1073\/pnas.0409500102.","journal-title":"Proc Natl Acad Sci USA."},{"issue":"17","key":"416_CR40","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","volume":"369","author":"FR Zhang","year":"2013","unstructured":"Zhang FR, Liu H, Irwanto A, Fu XA, Li Y, Yu GQ, et al. HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med. 2013;369(17):1620\u20138. https:\/\/doi.org\/10.1056\/NEJMoa1213096.","journal-title":"N Engl J Med"},{"issue":"4","key":"416_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamadermatol.2017.6484","volume":"154","author":"W Tangamornsuksan","year":"2018","unstructured":"Tangamornsuksan W, Lohitnavy M. Association between HLA-B*1301 and dapsone-induced cutaneous adverse drug reactions: a systematic review and meta-analysis. JAMA Dermatol. 2018;154(4):441\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2017.6484.","journal-title":"JAMA Dermatol."},{"issue":"9","key":"416_CR42","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/cid\/cit021","volume":"56","author":"DF Carr","year":"2013","unstructured":"Carr DF, Chaponda M, Jorgensen AL, Castro EC, van Oosterhout JJ, Khoo SH, et al. Association of human leukocyte antigen alleles and nevirapine hypersensitivity in a Malawian HIV-infected population. Clin Infect Dis. 2013;56(9):1330\u20139. https:\/\/doi.org\/10.1093\/cid\/cit021.","journal-title":"Clin Infect Dis"},{"key":"416_CR43","doi-asserted-by":"publisher","unstructured":"White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response. J Allergy Clin Immunol. 2015;136(2):219\u201334. https:\/\/doi.org\/10.1016\/j.jaci.2015.05.050 (quiz 35).","DOI":"10.1016\/j.jaci.2015.05.050"},{"issue":"2","key":"416_CR44","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","volume":"105","author":"NH Shear","year":"1986","unstructured":"Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med. 1986;105(2):179\u201384.","journal-title":"Ann Intern Med"},{"issue":"5","key":"416_CR45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","volume":"156","author":"T Shiohara","year":"2007","unstructured":"Shiohara T, Iijima M, Ikezawa Z, Hashimoto K. The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations. Br J Dermatol. 2007;156(5):1083\u20134. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07807.x.","journal-title":"Br J Dermatol"},{"issue":"7","key":"416_CR46","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","volume":"124","author":"P Cacoub","year":"2011","unstructured":"Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588\u201397. https:\/\/doi.org\/10.1016\/j.amjmed.2011.01.017.","journal-title":"Am J Med"},{"issue":"5","key":"416_CR47","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","volume":"157","author":"M Tohyama","year":"2007","unstructured":"Tohyama M, Hashimoto K, Yasukawa M, Kimura H, Horikawa T, Nakajima K, et al. Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;157(5):934\u201340. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.08167.x.","journal-title":"Br J Dermatol"},{"key":"416_CR48","doi-asserted-by":"publisher","unstructured":"Picard D, Janela B, Descamps V, D\u2019Incan M, Courville P, Jacquot S et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Sci Transl Med. 2010;2(46):46ra62. https:\/\/doi.org\/10.1126\/scitranslmed.3001116.","DOI":"10.1126\/scitranslmed.3001116"},{"issue":"12","key":"416_CR49","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","volume":"182","author":"R Takahashi","year":"2009","unstructured":"Takahashi R, Kano Y, Yamazaki Y, Kimishima M, Mizukawa Y, Shiohara T. Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome. J Immunol. 2009;182(12):8071\u20139. https:\/\/doi.org\/10.4049\/jimmunol.0804002.","journal-title":"J Immunol."},{"issue":"1","key":"416_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2332\/allergolint.55.1","volume":"55","author":"T Shiohara","year":"2006","unstructured":"Shiohara T, Inaoka M, Kano Y. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses. Allergol Int. 2006;55(1):1\u20138. https:\/\/doi.org\/10.2332\/allergolint.55.1.","journal-title":"Allergol Int."},{"key":"416_CR51","doi-asserted-by":"publisher","first-page":"5163129","DOI":"10.1155\/2018\/5163129","volume":"2018","author":"H Watanabe","year":"2018","unstructured":"Watanabe H. Recent advances in drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms. J Immunol Res. 2018;2018:5163129. https:\/\/doi.org\/10.1155\/2018\/5163129.","journal-title":"J Immunol Res."},{"issue":"2","key":"416_CR52","doi-asserted-by":"publisher","first-page":"e114","DOI":"10.1111\/pde.13408","volume":"35","author":"ML Chow","year":"2018","unstructured":"Chow ML, Kim D, Kamath S, Peng D, Luu M. Use of antiviral medications in drug reaction with eosinophilia and systemic symptoms (DRESS): a case of infantile DRESS. Pediatr Dermatol. 2018;35(2):e114\u20136. https:\/\/doi.org\/10.1111\/pde.13408.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"416_CR53","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1590\/S0365-05962012000300013","volume":"87","author":"PR Criado","year":"2012","unstructured":"Criado PR, Criado RF, Avancini JM, Santi CG. Drug reaction with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012;87(3):435\u201349.","journal-title":"An Bras Dermatol."},{"issue":"6","key":"416_CR54","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/bjd.14704","volume":"175","author":"M Pinto Gouveia","year":"2016","unstructured":"Pinto Gouveia M, Gameiro A, Coutinho I, Pereira N, Cardoso JC, Goncalo M. Overlap between maculopapular exanthema and drug reaction with eosinophilia and systemic symptoms among cutaneous adverse drug reactions in a dermatology ward. Br J Dermatol. 2016;175(6):1274\u201383. https:\/\/doi.org\/10.1111\/bjd.14704.","journal-title":"Br J Dermatol"},{"issue":"3","key":"416_CR55","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","volume":"29","author":"Y Kano","year":"2009","unstructured":"Kano Y, Shiohara T. The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug. Immunol Allergy Clin North Am. 2009;29(3):481\u2013501. https:\/\/doi.org\/10.1016\/j.iac.2009.04.007.","journal-title":"Immunol Allergy Clin North Am."},{"issue":"3","key":"416_CR56","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1346-8138.2010.01086.x","volume":"38","author":"S Hirakawa","year":"2011","unstructured":"Hirakawa S, Okazaki H, Sayama K, Tohyama M, Hashimoto K. Possible association of vascular endothelial growth factor with the development of edema in drug-induced hypersensitivity syndrome. J Dermatol. 2011;38(3):292\u20134. https:\/\/doi.org\/10.1111\/j.1346-8138.2010.01086.x.","journal-title":"J Dermatol"},{"issue":"5","key":"416_CR57","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/jdv.13033","volume":"30","author":"J Rakusa","year":"2016","unstructured":"Rakusa J, Lautenschlager S, Chmiel C. Allopurinol induced DRESS syndrome without eosinophilia and pronounced mucosal involvement. J Eur Acad Dermatol Venereol. 2016;30(5):865\u20137. https:\/\/doi.org\/10.1111\/jdv.13033.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"416_CR58","doi-asserted-by":"publisher","unstructured":"Kano Y, Ishida T, Hirahara K, Shiohara T. Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome. Med Clin North Am. 2010;94(4):743\u201359. https:\/\/doi.org\/10.1016\/j.mcna.2010.03.004 (xi).","DOI":"10.1016\/j.mcna.2010.03.004"},{"issue":"10","key":"416_CR59","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2169\/internalmedicine.55.6035","volume":"55","author":"L Ozisik","year":"2016","unstructured":"Ozisik L, Tanriover MD, Saka E. Autoimmune limbic encephalitis and syndrome of inappropriate antidiuretic hormone secretion associated with lamotrigine-induced drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Intern Med. 2016;55(10):1393\u20136. https:\/\/doi.org\/10.2169\/internalmedicine.55.6035.","journal-title":"Intern Med"},{"issue":"10","key":"416_CR60","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00234-015-1562-0","volume":"57","author":"M Gaha","year":"2015","unstructured":"Gaha M, Landry D, Belair M, Paquet B, Chapdelaine H, Bard C. DRESS syndrome: cerebral vasculitic-like presentation. Neuroradiology. 2015;57(10):1015\u201321. https:\/\/doi.org\/10.1007\/s00234-015-1562-0.","journal-title":"Neuroradiology"},{"issue":"3","key":"416_CR61","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156(3):609\u201311. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07704.x.","journal-title":"Br J Dermatol"},{"issue":"2","key":"416_CR62","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamadermatol.2013.6698","volume":"150","author":"F Tetart","year":"2014","unstructured":"Tetart F, Picard D, Janela B, Joly P, Musette P. Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features. JAMA Dermatol. 2014;150(2):206\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2013.6698.","journal-title":"JAMA Dermatol."},{"issue":"4","key":"416_CR63","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jdv.12419","volume":"29","author":"D Picard","year":"2015","unstructured":"Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P. Recurrence of drug-induced reactions in DRESS patients. J Eur Acad Dermatol Venereol. 2015;29(4):801\u20134. https:\/\/doi.org\/10.1111\/jdv.12419.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"416_CR64","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000095437","volume":"141","author":"R Wolf","year":"2006","unstructured":"Wolf R, Davidovici B, Matz H, Mahlab K, Orion E, Sthoeger ZM. Drug rash with eosinophilia and systemic symptoms versus Stevens-Johnson syndrome\u2014a case that indicates a stumbling block in the current classification. Int Arch Allergy Immunol. 2006;141(3):308\u201310. https:\/\/doi.org\/10.1159\/000095437.","journal-title":"Int Arch Allergy Immunol"},{"key":"416_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1750-1172-7-72","volume":"7","author":"S Bouvresse","year":"2012","unstructured":"Bouvresse S, Valeyrie-Allanore L, Ortonne N, Konstantinou MP, Kardaun SH, Bagot M, et al. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis. 2012;7:72. https:\/\/doi.org\/10.1186\/1750-1172-7-72.","journal-title":"Orphanet J Rare Dis."},{"issue":"3","key":"416_CR66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.clindermatol.2005.02.001","volume":"23","author":"R Wolf","year":"2005","unstructured":"Wolf R, Matz H, Marcos B, Orion E. Drug rash with eosinophilia and systemic symptoms vs toxic epidermal necrolysis: the dilemma of classification. Clin Dermatol. 2005;23(3):311\u20134. https:\/\/doi.org\/10.1016\/j.clindermatol.2005.02.001.","journal-title":"Clin Dermatol"},{"issue":"3","key":"416_CR67","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/15569527.2011.554481","volume":"30","author":"WL Teo","year":"2011","unstructured":"Teo WL, Pang SM, Koh HY. Allopurinol hypersensitivity syndrome with acute generalized exanthematous pustulosis manifestations. Cutan Ocul Toxicol. 2011;30(3):243\u20134. https:\/\/doi.org\/10.3109\/15569527.2011.554481.","journal-title":"Cutan Ocul Toxicol."},{"key":"416_CR68","doi-asserted-by":"publisher","unstructured":"Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. J Am Acad Dermatol. 2014;70(2):205.e1\u201316. https:\/\/doi.org\/10.1016\/j.jaad.2013.07.049 (quiz 21\u20132).","DOI":"10.1016\/j.jaad.2013.07.049"},{"issue":"5","key":"416_CR69","doi-asserted-by":"publisher","first-page":"e210","DOI":"10.1016\/j.jaad.2012.02.043","volume":"67","author":"C Gattringer","year":"2012","unstructured":"Gattringer C, Muller H, Steurer M, Steger C, Ratzinger G. Narrowband UVB therapy for the treatment of pruritus in hypereosinophilic syndrome: clinical report and review of the literature on phototherapy. J Am Acad Dermatol. 2012;67(5):e210\u20133. https:\/\/doi.org\/10.1016\/j.jaad.2012.02.043.","journal-title":"J Am Acad Dermatol"},{"key":"416_CR70","doi-asserted-by":"publisher","unstructured":"Benm\u2019rad M, Leclerc-Mercier S, Blanche P, Franck N, Rozenberg F, Fulla Y, et al. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients. Medicine. 2009;88(3):131\u201340. https:\/\/doi.org\/10.1097\/MD.0b013e3181a4d1a1.","DOI":"10.1097\/MD.0b013e3181a4d1a1"},{"key":"416_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","volume":"93","author":"R Giacomelli","year":"2018","unstructured":"Giacomelli R, Ruscitti P, Shoenfeld Y. A comprehensive review on adult onset Still\u2019s disease. J Autoimmun. 2018;93:24\u201336. https:\/\/doi.org\/10.1016\/j.jaut.2018.07.018.","journal-title":"J Autoimmun"},{"issue":"7","key":"416_CR72","doi-asserted-by":"publisher","first-page":"996","DOI":"10.3899\/jrheum.161286","volume":"44","author":"SS Ahn","year":"2017","unstructured":"Ahn SS, Yoo BW, Jung SM, Lee SW, Park YB, Song JJ. Application of the 2016 EULAR\/ACR\/PRINTO classification criteria for macrophage activation syndrome in patients with adult-onset Still disease. J Rheumatol. 2017;44(7):996\u20131003. https:\/\/doi.org\/10.3899\/jrheum.161286.","journal-title":"J Rheumatol"},{"issue":"3","key":"416_CR73","first-page":"424","volume":"19","author":"M Yamaguchi","year":"1992","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still\u2019s disease. J Rheumatol. 1992;19(3):424\u201330.","journal-title":"J Rheumatol"},{"issue":"1","key":"416_CR74","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00002018-200831010-00003","volume":"31","author":"TB Agbabiaka","year":"2008","unstructured":"Agbabiaka TB, Savovic J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf. 2008;31(1):21\u201337.","journal-title":"Drug Saf"},{"issue":"3","key":"416_CR75","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/cpt1977213247","volume":"21","author":"FE Karch","year":"1977","unstructured":"Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther. 1977;21(3):247\u201354.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"416_CR76","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239\u201345.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"416_CR77","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2125.1982.tb01361.x","volume":"13","author":"U Busto","year":"1982","unstructured":"Busto U, Naranjo CA, Sellers EM. Comparison of two recently published algorithms for assessing the probability of adverse drug reactions. Br J Clin Pharmacol. 1982;13(2):223\u20137.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"416_CR78","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/00003727-198208000-00009","volume":"5","author":"JK Jones","year":"1982","unstructured":"Jones JK. Adverse drug reactions in the community health setting: approaches to recognizing, counseling, and reporting. Fam Community Health. 1982;5(2):58\u201367.","journal-title":"Fam Community Health."},{"issue":"11","key":"416_CR79","first-page":"1441","volume":"163","author":"FL Paradiso-Hardy","year":"2000","unstructured":"Paradiso-Hardy FL, Angelo CM, Lanctot KL, Cohen EA. Hematologic dyscrasia associated with ticlopidine therapy: evidence for causality. CMAJ. 2000;163(11):1441\u20138.","journal-title":"CMAJ"},{"issue":"3","key":"416_CR80","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/jcpt.12520","volume":"42","author":"WA Watson","year":"2017","unstructured":"Watson WA, Rhodes NJ, Echenique IA, Angarone MP, Scheetz MH. Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: a case report and review of the literature. J Clin Pharm Ther. 2017;42(3):350\u20135. https:\/\/doi.org\/10.1111\/jcpt.12520.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"416_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40264-014-0249-5","volume":"38","author":"B Osimani","year":"2015","unstructured":"Osimani B, Mignini F. Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms? Drug Saf. 2015;38(1):1\u201311. https:\/\/doi.org\/10.1007\/s40264-014-0249-5.","journal-title":"Drug Saf"},{"key":"416_CR82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.artmed.2018.07.005","volume":"91","author":"PP Rodrigues","year":"2018","unstructured":"Rodrigues PP, Ferreira-Santos D, Silva A, Polonia J, Ribeiro-Vaz I. Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network. Artif Intell Med. 2018;91:12\u201322. https:\/\/doi.org\/10.1016\/j.artmed.2018.07.005.","journal-title":"Artif Intell Med"},{"issue":"3","key":"416_CR83","first-page":"213","volume":"8","author":"BM Ghajar","year":"1989","unstructured":"Ghajar BM, Lanctot KL, Shear NH, Naranjo CA. Bayesian differential diagnosis of a cutaneous reaction associated with the administration of sulfonamides. Semin Dermatol. 1989;8(3):213\u20138.","journal-title":"Semin Dermatol"},{"issue":"10","key":"416_CR84","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/j.1552-4604.1992.tb04635.x","volume":"32","author":"CA Naranjo","year":"1992","unstructured":"Naranjo CA, Shear NH, Lanctot KL. Advances in the diagnosis of adverse drug reactions. J Clin Pharmacol. 1992;32(10):897\u2013904.","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"416_CR85","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010;88(1):60\u20138. https:\/\/doi.org\/10.1038\/clpt.2009.252.","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"416_CR86","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","volume":"36","author":"SN Ramasamy","year":"2013","unstructured":"Ramasamy SN, Korb-Wells CS, Kannangara DR, Smith MW, Wang N, Roberts DM, et al. Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. Drug Saf. 2013;36(10):953\u201380. https:\/\/doi.org\/10.1007\/s40264-013-0084-0.","journal-title":"Drug Saf"},{"issue":"8","key":"416_CR87","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1002\/art.34488","volume":"64","author":"LK Stamp","year":"2012","unstructured":"Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, et al. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum. 2012;64(8):2529\u201336. https:\/\/doi.org\/10.1002\/art.34488.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"416_CR88","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1001\/archderm.1990.01670250100017","volume":"126","author":"NH Shear","year":"1990","unstructured":"Shear NH. Diagnosing cutaneous adverse reactions to drugs. Arch Dermatol. 1990;126(1):94\u20137.","journal-title":"Arch Dermatol"},{"issue":"16","key":"416_CR89","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1097\/00002030-200211080-00017","volume":"16","author":"EJ Phillips","year":"2002","unstructured":"Phillips EJ, Sullivan JR, Knowles SR, Shear NH. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS. 2002;16(16):2223\u20135.","journal-title":"AIDS."},{"issue":"5","key":"416_CR90","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2165\/00002018-200932050-00003","volume":"32","author":"AA Elzagallaai","year":"2009","unstructured":"Elzagallaai AA, Knowles SR, Rieder MJ, Bend JR, Shear NH, Koren G. Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic review. Drug Saf. 2009;32(5):391\u2013408. https:\/\/doi.org\/10.2165\/00002018-200932050-00003.","journal-title":"Drug Saf"},{"key":"416_CR91","doi-asserted-by":"crossref","unstructured":"Barbaud A, Goncalo M, Bruynzeel D, Bircher A; European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45(6):321\u20138.","DOI":"10.1034\/j.1600-0536.2001.450601.x"},{"issue":"6","key":"416_CR92","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/all.12142","volume":"68","author":"K Brockow","year":"2013","unstructured":"Brockow K, Garvey LH, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs\u2014an ENDA\/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702\u201312. https:\/\/doi.org\/10.1111\/all.12142.","journal-title":"Allergy"},{"issue":"4","key":"416_CR93","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/cod.12432","volume":"73","author":"JD Johansen","year":"2015","unstructured":"Johansen JD, Aalto-Korte K, Agner T, Andersen KE, Bircher A, Bruze M, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing\u2014recommendations on best practice. Contact Dermatitis. 2015;73(4):195\u2013221. https:\/\/doi.org\/10.1111\/cod.12432.","journal-title":"Contact Dermatitis."},{"issue":"2","key":"416_CR94","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archderm.1989.01670140151033","volume":"125","author":"L Vaillant","year":"1989","unstructured":"Vaillant L, Camenen I, Lorette G. Patch testing with carbamazepine: reinduction of an exfoliative dermatitis. Arch Dermatol. 1989;125(2):299.","journal-title":"Arch Dermatol"},{"issue":"5","key":"416_CR95","first-page":"312","volume":"42","author":"TS Sanchez","year":"2000","unstructured":"Sanchez TS, Sanchez-Perez J, Aragues M, Garcia-Diaz A. Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test. Contact Dermatitis. 2000;42(5):312\u20133.","journal-title":"Contact Dermatitis."},{"issue":"1","key":"416_CR96","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1046\/j.1365-2133.1998.02313.x","volume":"139","author":"A Barbaud","year":"1998","unstructured":"Barbaud A, Reichert-Penetrat S, Trechot P, Jacquin-Petit MA, Ehlinger A, Noirez V, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139(1):49\u201358.","journal-title":"Br J Dermatol"},{"issue":"6","key":"416_CR97","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/j.1600-0536.1995.tb02099.x","volume":"33","author":"CE Klein","year":"1995","unstructured":"Klein CE, Trautmann A, Zillikens D, Brocker EB. Patch testing in an unusual case of toxic epidermal necrolysis. Contact Dermatitis. 1995;33(6):448\u20139.","journal-title":"Contact Dermatitis."},{"issue":"5","key":"416_CR98","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1600-0536.1993.tb03560.x","volume":"29","author":"K Alanko","year":"1993","unstructured":"Alanko K. Patch testing in cutaneous reactions caused by carbamazepine. Contact Dermatitis. 1993;29(5):254\u20137.","journal-title":"Contact Dermatitis."},{"issue":"4","key":"416_CR99","first-page":"287","volume":"50","author":"DS Wilkinson","year":"1970","unstructured":"Wilkinson DS, Fregert S, Magnusson B, Bandmann HJ, Calnan CD, Cronin E, et al. Terminology of contact dermatitis. Acta Derm Venereol. 1970;50(4):287\u201392.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"416_CR100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.0105-4538.2001.00001.x-i8","volume":"57","author":"K Brockow","year":"2002","unstructured":"Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45\u201351.","journal-title":"Allergy"},{"issue":"6","key":"416_CR101","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11882-014-0442-8","volume":"14","author":"A Barbaud","year":"2014","unstructured":"Barbaud A. Skin testing and patch testing in non-IgE-mediated drug allergy. Curr Allergy Asthma Rep. 2014;14(6):442. https:\/\/doi.org\/10.1007\/s11882-014-0442-8.","journal-title":"Curr Allergy Asthma Rep."},{"issue":"3","key":"416_CR102","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1600-0536.2009.01695.x","volume":"62","author":"JS Wee","year":"2010","unstructured":"Wee JS, White JM, McFadden JP, White IR. Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis. 2010;62(3):165\u20139. https:\/\/doi.org\/10.1111\/j.1600-0536.2009.01695.x.","journal-title":"Contact Dermatitis."},{"issue":"5","key":"416_CR103","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1111\/j.0105-1873.2004.00340.x","volume":"50","author":"I Anveden","year":"2004","unstructured":"Anveden I, Lindberg M, Andersen KE, Bruze M, Isaksson M, Liden C, et al. Oral prednisone suppresses allergic but not irritant patch test reactions in individuals hypersensitive to nickel. Contact Dermatitis. 2004;50(5):298\u2013303. https:\/\/doi.org\/10.1111\/j.0105-1873.2004.00340.x.","journal-title":"Contact Dermatitis."},{"issue":"3","key":"416_CR104","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ced.12239","volume":"39","author":"S Ohtoshi","year":"2014","unstructured":"Ohtoshi S, Kitami Y, Sueki H, Nakada T. Utility of patch testing for patients with drug eruption. Clin Exp Dermatol. 2014;39(3):279\u201383. https:\/\/doi.org\/10.1111\/ced.12239.","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"416_CR105","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","volume":"168","author":"A Barbaud","year":"2013","unstructured":"Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168(3):555\u201362. https:\/\/doi.org\/10.1111\/bjd.12125.","journal-title":"Br J Dermatol"},{"issue":"1","key":"416_CR106","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","volume":"62","author":"F Santiago","year":"2010","unstructured":"Santiago F, Goncalo M, Vieira R, Coelho S, Figueiredo A. Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS). Contact Dermatitis. 2010;62(1):47\u201353. https:\/\/doi.org\/10.1111\/j.1600-0536.2009.01659.x.","journal-title":"Contact Dermatitis."},{"issue":"8","key":"416_CR107","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/all.12886","volume":"71","author":"C Mayorga","year":"2016","unstructured":"Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P, Rodrigues-Cernadas J, et al. In vitro tests for drug hypersensitivity reactions: an ENDA\/EAACI Drug Allergy Interest Group position paper. Allergy. 2016;71(8):1103\u201334. https:\/\/doi.org\/10.1111\/all.12886.","journal-title":"Allergy"},{"issue":"8","key":"416_CR108","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","volume":"59","author":"WJ Pichler","year":"2004","unstructured":"Pichler WJ, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy. 2004;59(8):809\u201320. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00547.x.","journal-title":"Allergy"},{"issue":"9","key":"416_CR109","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","volume":"31","author":"Y Hari","year":"2001","unstructured":"Hari Y, Frutig-Schnyder K, Hurni M, Yawalkar N, Zanni MP, Schnyder B, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy. 2001;31(9):1398\u2013408.","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"416_CR110","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1034\/j.1398-9995.2001.000115.x","volume":"56","author":"I Luque","year":"2001","unstructured":"Luque I, Leyva L, Jose Torres M, Rosal M, Mayorga C, Segura JM, et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy. 2001;56(7):611\u20138.","journal-title":"Allergy"},{"issue":"3","key":"416_CR111","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/cea.13076","volume":"48","author":"R Cabanas","year":"2018","unstructured":"Cabanas R, Calderon O, Ramirez E, Fiandor A, Caballero T, Heredia R, et al. Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment. Clin Exp Allergy. 2018;48(3):325\u201333. https:\/\/doi.org\/10.1111\/cea.13076.","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"416_CR112","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1684\/ecn.2008.0132","volume":"19","author":"G Khalil","year":"2008","unstructured":"Khalil G, El-Sabban M, Al-Ghadban S, Azzi S, Shamra S, Khalife S, et al. Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin. Eur Cytokine Netw. 2008;19(3):131\u201341. https:\/\/doi.org\/10.1684\/ecn.2008.0132.","journal-title":"Eur Cytokine Netw"},{"issue":"3","key":"416_CR113","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjd.12109","volume":"168","author":"ME Polak","year":"2013","unstructured":"Polak ME, Belgi G, McGuire C, Pickard C, Healy E, Friedmann PS, et al. In vitro diagnostic assays are effective during the acute phase of delayed-type drug hypersensitivity reactions. Br J Dermatol. 2013;168(3):539\u201349. https:\/\/doi.org\/10.1111\/bjd.12109.","journal-title":"Br J Dermatol"},{"key":"416_CR114","doi-asserted-by":"publisher","unstructured":"Suthumchai N, Srinoulprasert Y, Thantiworasit P, Rerknimitr P, Tuchinda P, Chularojanamontri L, et al. The measurement of drug-induced interferon gamma-releasing cells and lymphocyte proliferation in severe cutaneous adverse reactions. J Eur Acad Dermatol Venereol. 2018. https:\/\/doi.org\/10.1111\/jdv.14890.","DOI":"10.1111\/jdv.14890"},{"issue":"4","key":"416_CR115","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1398-9995.2008.01674.x","volume":"64","author":"A Rozieres","year":"2009","unstructured":"Rozieres A, Hennino A, Rodet K, Gutowski MC, Gunera-Saad N, Berard F, et al. Detection and quantification of drug-specific T cells in penicillin allergy. Allergy. 2009;64(4):534\u201342. https:\/\/doi.org\/10.1111\/j.1398-9995.2008.01674.x.","journal-title":"Allergy"},{"issue":"5","key":"416_CR116","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1111\/bjd.14701","volume":"175","author":"J Klaewsongkram","year":"2016","unstructured":"Klaewsongkram J, Thantiworasit P, Suthumchai N, Rerknimitr P, Sukasem C, Tuchinda P, et al. In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions. Br J Dermatol. 2016;175(5):994\u20131002. https:\/\/doi.org\/10.1111\/bjd.14701.","journal-title":"Br J Dermatol"},{"issue":"4","key":"416_CR117","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/bjd.12783","volume":"170","author":"MH Chi","year":"2014","unstructured":"Chi MH, Hui RC, Yang CH, Lin JY, Lin YT, Ho HC, et al. Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS). Br J Dermatol. 2014;170(4):866\u201373. https:\/\/doi.org\/10.1111\/bjd.12783.","journal-title":"Br J Dermatol"},{"issue":"2","key":"416_CR118","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/bjd.12081","volume":"168","author":"S Walsh","year":"2013","unstructured":"Walsh S, Diaz-Cano S, Higgins E, Morris-Jones R, Bashir S, Bernal W, et al. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases. Br J Dermatol. 2013;168(2):391\u2013401. https:\/\/doi.org\/10.1111\/bjd.12081.","journal-title":"Br J Dermatol"},{"issue":"9","key":"416_CR119","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","volume":"22","author":"CC Chiou","year":"2008","unstructured":"Chiou CC, Yang LC, Hung SI, Chang YC, Kuo TT, Ho HC, et al. Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan. J Eur Acad Dermatol Venereol. 2008;22(9):1044\u20139. https:\/\/doi.org\/10.1111\/j.1468-3083.2008.02585.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"416_CR120","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/bjd.13683","volume":"173","author":"N Ortonne","year":"2015","unstructured":"Ortonne N, Valeyrie-Allanore L, Bastuji-Garin S, Wechsler J, de Feraudy S, Duong TA, et al. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study. Br J Dermatol. 2015;173(1):50\u20138. https:\/\/doi.org\/10.1111\/bjd.13683.","journal-title":"Br J Dermatol"},{"issue":"14","key":"416_CR121","first-page":"597","volume":"1","author":"N Brinster","year":"2012","unstructured":"Brinster N. Cutaneous adverse reactions to drugs. McKee\u2019s pathology of the skin. 2012;1(14):597\u20138.","journal-title":"McKee\u2019s pathology of the skin."},{"key":"416_CR122","unstructured":"Hughes MP, Pellowski DM, Hiatt KM. Cutaneous toxicities of drugs. In: Elder DE, editor. Lever\u2019s histopathology of the skin. 11th ed. Philadelphia: Wolters Kluwer; 2015. pp. 365\u2013394"},{"issue":"3","key":"416_CR123","first-page":"291","volume":"149","author":"G Borroni","year":"2014","unstructured":"Borroni G, Torti S, Pezzini C, Vassallo C, Rosso R, D\u2019Ospina RM, et al. Histopathologic spectrum of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a diagnosis that needs clinico-pathological correlation. G Ital Dermatol Venereol. 2014;149(3):291\u2013300.","journal-title":"G Ital Dermatol Venereol."},{"issue":"6","key":"416_CR124","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/DAD.0000000000000439","volume":"38","author":"MM Goncalo","year":"2016","unstructured":"Goncalo MM, Cardoso JC, Gouveia MP, Coutinho I, Gameiro AR, Brites MM, et al. Histopathology of the exanthema in DRESS is not specific but may indicate severity of systemic involvement. Am J Dermatopathol. 2016;38(6):423\u201333. https:\/\/doi.org\/10.1097\/DAD.0000000000000439.","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"416_CR125","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaad.2014.10.032","volume":"72","author":"E Funck-Brentano","year":"2015","unstructured":"Funck-Brentano E, Duong TA, Bouvresse S, Bagot M, Wolkenstein P, Roujeau JC, et al. Therapeutic management of DRESS: a retrospective study of 38 cases. J Am Acad Dermatol. 2015;72(2):246\u201352. https:\/\/doi.org\/10.1016\/j.jaad.2014.10.032.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"416_CR126","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1468-3083.2012.04547.x","volume":"27","author":"H Uhara","year":"2013","unstructured":"Uhara H, Saiki M, Kawachi S, Ashida A, Oguchi S, Okuyama R. Clinical course of drug-induced hypersensitivity syndrome treated without systemic corticosteroids. J Eur Acad Dermatol Venereol. 2013;27(6):722\u20136. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04547.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"416_CR127","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archderm.145.1.67","volume":"145","author":"M Eshki","year":"2009","unstructured":"Eshki M, Allanore L, Musette P, Milpied B, Grange A, Guillaume JC, et al. Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure. Arch Dermatol. 2009;145(1):67\u201372. https:\/\/doi.org\/10.1001\/archderm.145.1.67.","journal-title":"Arch Dermatol"},{"issue":"11","key":"416_CR128","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.annder.2010.04.024","volume":"137","author":"V Descamps","year":"2010","unstructured":"Descamps V, Ben Said B, Sassolas B, Truchetet F, Avenel-Audran M, Girardin P, et al. Management of drug reaction with eosinophilia and systemic symptoms (DRESS) [in French]. Ann Dermatol Venereol. 2010;137(11):703\u20138. https:\/\/doi.org\/10.1016\/j.annder.2010.04.024.","journal-title":"Ann Dermatol Venereol"},{"key":"416_CR129","doi-asserted-by":"publisher","unstructured":"Husain Z, Reddy BY, Schwartz RA. DRESS syndrome: part II. Management and therapeutics. J Am Acad Dermatol. 2013;68(5):709.e1\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2013.01.032 (quiz 18\u201320).","DOI":"10.1016\/j.jaad.2013.01.032"},{"key":"416_CR130","doi-asserted-by":"publisher","first-page":"928910","DOI":"10.1155\/2013\/928910","volume":"2013","author":"C Kocaoglu","year":"2013","unstructured":"Kocaoglu C, Cilasun C, Solak ES, Kurtipek GS, Arslan S. Successful treatment of antiepileptic drug-induced DRESS syndrome with pulse methylprednisolone. Case Rep Pediatr. 2013;2013:928910. https:\/\/doi.org\/10.1155\/2013\/928910.","journal-title":"Case Rep Pediatr."},{"issue":"3","key":"416_CR131","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1684\/ejd.2011.1300","volume":"21","author":"J Natkunarajah","year":"2011","unstructured":"Natkunarajah J, Goolamali S, Craythorne E, Benton E, Smith C, Morris-Jones R, et al. Ten cases of drug reaction with eosinophilia and systemic symptoms (DRESS) treated with pulsed intravenous methylprednisolone. Eur J Dermatol. 2011;21(3):385\u201391. https:\/\/doi.org\/10.1684\/ejd.2011.1300.","journal-title":"Eur J Dermatol."},{"issue":"5","key":"416_CR132","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jaad.2012.10.017","volume":"68","author":"Y Ushigome","year":"2013","unstructured":"Ushigome Y, Kano Y, Ishida T, Hirahara K, Shiohara T. Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution. J Am Acad Dermatol. 2013;68(5):721\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2012.10.017.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"416_CR133","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/archdermatol.2009.195","volume":"145","author":"Y Asano","year":"2009","unstructured":"Asano Y, Kagawa H, Kano Y, Shiohara T. Cytomegalovirus disease during severe drug eruptions. Arch Dermatol. 2009;145(9):1030\u20136.","journal-title":"Arch Dermatol"},{"issue":"6","key":"416_CR134","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/j.jaad.2010.11.057","volume":"66","author":"GP Bourgeois","year":"2012","unstructured":"Bourgeois GP, Cafardi JA, Groysman V, Hughey LC. A review of DRESS-associated myocarditis. J Am Acad Dermatol. 2012;66(6):e229\u201336. https:\/\/doi.org\/10.1016\/j.jaad.2010.11.057.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"416_CR135","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamadermatol.2016.2220","volume":"152","author":"MG Kirchhof","year":"2016","unstructured":"Kirchhof MG, Wong A, Dutz JP. Cyclosporine treatment of drug-induced hypersensitivity syndrome. JAMA Dermatol. 2016;152(11):1254\u20137. https:\/\/doi.org\/10.1001\/jamadermatol.2016.2220.","journal-title":"JAMA Dermatol."},{"issue":"4","key":"416_CR136","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1365-2230.2003.01267.x","volume":"28","author":"KE Harman","year":"2003","unstructured":"Harman KE, Morris SD, Higgins EM. Persistent anticonvulsant hypersensitivity syndrome responding to ciclosporin. Clin Exp Dermatol. 2003;28(4):364\u20135.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"416_CR137","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5414\/CNP64155","volume":"64","author":"E Zuliani","year":"2005","unstructured":"Zuliani E, Zwahlen H, Gilliet F, Marone C. Vancomycin-induced hypersensitivity reaction with acute renal failure: resolution following cyclosporine treatment. Clin Nephrol. 2005;64(2):155\u20138.","journal-title":"Clin Nephrol"},{"issue":"3","key":"416_CR138","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3346\/jkms.2008.23.3.521","volume":"23","author":"JH Lee","year":"2008","unstructured":"Lee JH, Park HK, Heo J, Kim TO, Kim GH, Kang DH, et al. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs. J Korean Med Sci. 2008;23(3):521\u20135. https:\/\/doi.org\/10.3346\/jkms.2008.23.3.521.","journal-title":"J Korean Med Sci"},{"key":"416_CR139","doi-asserted-by":"publisher","unstructured":"Daoulah A, Alqahtani AA, Ocheltree SR, Alhabib A, Ocheltree AR. Acute myocardial infarction in a 56-year-old female patient treated with sulfasalazine. Am J Emerg Med. 2012;30(4):638e1\u20133. https:\/\/doi.org\/10.1016\/j.ajem.2011.02.018.","DOI":"10.1016\/j.ajem.2011.02.018"},{"issue":"4","key":"416_CR140","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.jaad.2010.12.013","volume":"65","author":"GP Bourgeois","year":"2011","unstructured":"Bourgeois GP, Cafardi JA, Groysman V, Pamboukian SV, Kirklin JK, Andea AA, et al. Fulminant myocarditis as a late sequela of DRESS: two cases. J Am Acad Dermatol. 2011;65(4):889\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2010.12.013.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"416_CR141","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.tox.2004.12.013","volume":"209","author":"Y Kano","year":"2005","unstructured":"Kano Y, Inaoka M, Sakuma K, Shiohara T. Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome. Toxicology. 2005;209(2):165\u20137. https:\/\/doi.org\/10.1016\/j.tox.2004.12.013.","journal-title":"Toxicology"},{"issue":"4 Suppl","key":"416_CR142","doi-asserted-by":"publisher","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","volume":"117","author":"JS Orange","year":"2006","unstructured":"Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006;117(4 Suppl):S525\u201353. https:\/\/doi.org\/10.1016\/j.jaci.2006.01.015.","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"416_CR143","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2340\/00015555-1168","volume":"92","author":"Y Kito","year":"2012","unstructured":"Kito Y, Ito T, Tokura Y, Hashizume H. High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome. Acta Derm Venereol. 2012;92(1):100\u20131. https:\/\/doi.org\/10.2340\/00015555-1168.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"416_CR144","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1001\/jamadermatol.2013.1949","volume":"149","author":"EM Singer","year":"2013","unstructured":"Singer EM, Wanat KA, Rosenbach MA. A case of recalcitrant DRESS syndrome with multiple autoimmune sequelae treated with intravenous immunoglobulins. JAMA Dermatol. 2013;149(4):494\u20135. https:\/\/doi.org\/10.1001\/jamadermatol.2013.1949.","journal-title":"JAMA Dermatol."},{"issue":"11","key":"416_CR145","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1097\/INF.0b013e318125655d","volume":"26","author":"RP Santos","year":"2007","unstructured":"Santos RP, Ramilo O, Barton T. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection. Pediatr Infect Dis J. 2007;26(11):1053\u20136. https:\/\/doi.org\/10.1097\/INF.0b013e318125655d.","journal-title":"Pediatr Infect Dis J."},{"issue":"4","key":"416_CR146","first-page":"510","volume":"4","author":"KS Fields","year":"2005","unstructured":"Fields KS, Petersen MJ, Chiao E, Tristani-Firouzi P. Case reports: treatment of nevirapine-associated dress syndrome with intravenous immune globulin (IVIG). J Drugs Dermatol. 2005;4(4):510\u20133.","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"416_CR147","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archderm.148.4.dlt120002-c","volume":"148","author":"P Joly","year":"2012","unstructured":"Joly P, Janela B, Tetart F, Rogez S, Picard D, D\u2019Incan M, et al. Poor benefit\/risk balance of intravenous immunoglobulins in DRESS. Arch Dermatol. 2012;148(4):543\u20134. https:\/\/doi.org\/10.1001\/archderm.148.4.dlt120002-c.","journal-title":"Arch Dermatol"},{"issue":"5 Suppl","key":"416_CR148","first-page":"A29","volume":"113","author":"M Mortezavi","year":"2014","unstructured":"Mortezavi M, Lomas JM, Looner RJ. Treatment of drug reaction with eosinophillia and systemic symptoms (DRESS) with mycophenolate mofetil as a steroid sparing agent [abstract]. Ann Allergy Asthma Immunol. 2014;113(5 Suppl):A29.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"416_CR149","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jaad.2009.05.046","volume":"62","author":"KK Shaughnessy","year":"2010","unstructured":"Shaughnessy KK, Bouchard SM, Mohr MR, Herre JM, Salkey KS. Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis. J Am Acad Dermatol. 2010;62(2):315\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2009.05.046.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"416_CR150","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2009.10.054","volume":"55","author":"E Laban","year":"2010","unstructured":"Laban E, Hainaut-Wierzbicka E, Pourreau F, Yacoub M, Sztermer E, Guillet G, et al. Cyclophosphamide therapy for corticoresistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in a patient with severe kidney and eye involvement and Epstein-Barr virus reactivation. Am J Kidney Dis. 2010;55(3):e11\u20134. https:\/\/doi.org\/10.1053\/j.ajkd.2009.10.054.","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"416_CR151","doi-asserted-by":"publisher","first-page":"e945","DOI":"10.1542\/peds.2012-2117","volume":"131","author":"T Alexander","year":"2013","unstructured":"Alexander T, Iglesia E, Park Y, Duncan D, Peden D, Sheikh S, et al. Severe DRESS syndrome managed with therapeutic plasma exchange. Pediatrics. 2013;131(3):e945\u20139. https:\/\/doi.org\/10.1542\/peds.2012-2117.","journal-title":"Pediatrics"},{"key":"416_CR152","doi-asserted-by":"crossref","unstructured":"Moling O, Tappeiner L, Piccin A, Pagani E, Rossi P, Rimenti G, et al. Treatment of DIHS\/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir\u2014a hypothesis. Med Sci Monit. 2012;18(7):CS57\u201362.","DOI":"10.12659\/MSM.883198"},{"issue":"2\u20133","key":"416_CR153","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0379-0738(01)00476-5","volume":"122","author":"G Lau","year":"2001","unstructured":"Lau G, Kwan C, Chong SM. The 3-week sulphasalazine syndrome strikes again. Forensic Sci Int. 2001;122(2\u20133):79\u201384.","journal-title":"Forensic Sci Int"},{"issue":"4","key":"416_CR154","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2133.1997.tb02175.x","volume":"136","author":"P Redondo","year":"1997","unstructured":"Redondo P, de Felipe I, de la Pena A, Aramendia JM, Vanaclocha V. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine. Br J Dermatol. 1997;136(4):645\u20136.","journal-title":"Br J Dermatol."},{"issue":"5","key":"416_CR155","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1046\/j.1365-2133.2001.04428.x","volume":"145","author":"S Tas","year":"2001","unstructured":"Tas S, Simonart T, Heenen M. Angio-oedema caused by high doses of N-acetylcysteine in patients with anticonvulsant hypersensitivity syndrome. Br J Dermatol. 2001;145(5):856\u20137.","journal-title":"Br J Dermatol"},{"issue":"2","key":"416_CR156","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","volume":"155","author":"H Peyriere","year":"2006","unstructured":"Peyriere H, Dereure O, Breton H, Demoly P, Cociglio M, Blayac JP, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2006;155(2):422\u20138. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07284.x.","journal-title":"Br J Dermatol."},{"issue":"6","key":"416_CR157","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1684\/ejd.2011.1550","volume":"21","author":"CH Wei","year":"2011","unstructured":"Wei CH, Chung-Yee Hui R, Chang CJ, Ho HC, Yang CH, Lin YJ, et al. Identifying prognostic factors for drug rash with eosinophilia and systemic symptoms (DRESS). Eur J Dermatol. 2011;21(6):930\u20137. https:\/\/doi.org\/10.1684\/ejd.2011.1550.","journal-title":"Eur J Dermatol."},{"issue":"2","key":"416_CR158","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cld.2012.03.002","volume":"16","author":"TJ Davern","year":"2012","unstructured":"Davern TJ. Drug-induced liver disease. Clin Liver Dis. 2012;16(2):231\u201345. https:\/\/doi.org\/10.1016\/j.cld.2012.03.002.","journal-title":"Clin Liver Dis"},{"issue":"3","key":"416_CR159","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/1346-8138.12770","volume":"42","author":"Y Kano","year":"2015","unstructured":"Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, et al. Sequelae in 145 patients with drug-induced hypersensitivity syndrome\/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR). J Dermatol. 2015;42(3):276\u201382. https:\/\/doi.org\/10.1111\/1346-8138.12770.","journal-title":"J Dermatol"},{"issue":"5","key":"416_CR160","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1468-3083.2012.04560.x","volume":"27","author":"H Hashizume","year":"2013","unstructured":"Hashizume H, Hata M. Deep venous thrombosis associated with cytomegalovirus reactivation in drug-induced hypersensitivity syndrome. J Eur Acad Dermatol Venereol. 2013;27(5):658\u20139. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04560.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"416_CR161","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2340\/00015555-1317","volume":"92","author":"Y Kano","year":"2012","unstructured":"Kano Y, Horie C, Inaoka M, Tadashi I, Mizukawa Y, Shiohara T. Herpes zoster in patients with drug-induced hypersensitivity syndrome\/DRESS. Acta Derm Venereol. 2012;92(2):206\u20137. https:\/\/doi.org\/10.2340\/00015555-1317.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"416_CR162","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/archdermatol.2008.521","volume":"145","author":"RJ Brown","year":"2009","unstructured":"Brown RJ, Rother KI, Artman H, Mercurio MG, Wang R, Looney RJ, et al. Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae. Arch Dermatol. 2009;145(1):63\u20136. https:\/\/doi.org\/10.1001\/archdermatol.2008.521.","journal-title":"Arch Dermatol"},{"issue":"4","key":"416_CR163","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2340\/00015555-2867","volume":"98","author":"X Wu","year":"2018","unstructured":"Wu X, Yang F, Chen S, Xiong H, Zhu Q, Gao X, et al. Clinical, viral and genetic characteristics of drug reaction with eosinophilia and systemic symptoms (DRESS) in Shanghai. China. Acta Derm Venereol. 2018;98(4):401\u20135. https:\/\/doi.org\/10.2340\/00015555-2867.","journal-title":"China. Acta Derm Venereol."},{"issue":"5","key":"416_CR164","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/j.1365-2133.2007.07784.x","volume":"156","author":"Y Kano","year":"2007","unstructured":"Kano Y, Sakuma K, Shiohara T. Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome. Br J Dermatol. 2007;156(5):1061\u20133. https:\/\/doi.org\/10.1111\/j.1365-2133.2007.07784.x.","journal-title":"Br J Dermatol"},{"key":"416_CR165","doi-asserted-by":"publisher","unstructured":"Aota N, Hirahara K, Kano Y, Fukuoka T, Yamada A, Shiohara T. Systemic lupus erythematosus presenting with Kikuchi-Fujimoto\u2019s disease as a long-term sequela of drug-induced hypersensitivity syndrome. A possible role of Epstein-Barr virus reactivation. Dermatology. 2009;218(3):275\u20137. https:\/\/doi.org\/10.1159\/000187619.","DOI":"10.1159\/000187619"},{"key":"416_CR166","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fmicb.2011.00005","volume":"2","author":"MR Chen","year":"2011","unstructured":"Chen MR. Epstein-Barr virus, the immune system, and associated diseases. Front Microbiol. 2011;2:5. https:\/\/doi.org\/10.3389\/fmicb.2011.00005.","journal-title":"Front Microbiol."},{"issue":"1\u20132","key":"416_CR167","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","volume":"33","author":"T Shiohara","year":"2007","unstructured":"Shiohara T, Kano Y. A complex interaction between drug allergy and viral infection. Clin Rev Allergy Immunol. 2007;33(1\u20132):124\u201333. https:\/\/doi.org\/10.1007\/s12016-007-8010-9.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"416_CR168","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","volume":"68","author":"YC Chen","year":"2013","unstructured":"Chen YC, Chang CY, Cho YT, Chiu HC, Chu CY. Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan. J Am Acad Dermatol. 2013;68(3):459\u201365. https:\/\/doi.org\/10.1016\/j.jaad.2012.08.009.","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"416_CR169","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-4632.2011.05213.x","volume":"52","author":"Y Minegaki","year":"2013","unstructured":"Minegaki Y, Higashida Y, Ogawa M, Miyachi Y, Fujii H, Kabashima K. Drug-induced hypersensitivity syndrome complicated with concurrent fulminant type 1 diabetes mellitus and Hashimoto\u2019s thyroiditis. Int J Dermatol. 2013;52(3):355\u20137. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05213.x.","journal-title":"Int J Dermatol"},{"issue":"2 Suppl","key":"416_CR170","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.jaad.2005.03.057","volume":"54","author":"CC Chiou","year":"2006","unstructured":"Chiou CC, Chung WH, Hung SI, Yang LC, Hong HS. Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection. J Am Acad Dermatol. 2006;54(2 Suppl):S14\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2005.03.057.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"416_CR171","first-page":"556","volume":"20","author":"SJ Um","year":"2010","unstructured":"Um SJ, Lee SK, Kim YH, Kim KH, Son CH, Roh MS, et al. Clinical features of drug-induced hypersensitivity syndrome in 38 patients. J Investig Allergol Clin Immunol. 2010;20(7):556\u201362.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"416_CR172","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.aller.2013.08.003","volume":"43","author":"YH Nam","year":"2015","unstructured":"Nam YH, Park MR, Nam HJ, Lee SK, Kim KH, Roh MS, et al. Drug reaction with eosinophilia and systemic symptoms syndrome is not uncommon and shows better clinical outcome than generally recognised. Allergol Immunopathol (Madr). 2015;43(1):19\u201324. https:\/\/doi.org\/10.1016\/j.aller.2013.08.003.","journal-title":"Allergol Immunopathol (Madr)."},{"issue":"3","key":"416_CR173","first-page":"301","volume":"137","author":"V Descamps","year":"2001","unstructured":"Descamps V, Valance A, Edlinger C, Fillet AM, Grossin M, Lebrun-Vignes B, et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol. 2001;137(3):301\u20134.","journal-title":"Arch Dermatol"},{"issue":"2","key":"416_CR174","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2340\/00015555-1222","volume":"92","author":"P Wongkitisophon","year":"2012","unstructured":"Wongkitisophon P, Chanprapaph K, Rattanakaemakorn P, Vachiramon V. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. Acta Derm Venereol. 2012;92(2):200\u20135. https:\/\/doi.org\/10.2340\/00015555-1222.","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"416_CR175","doi-asserted-by":"publisher","first-page":"163","DOI":"10.4103\/ijstd.IJSTD_70_17","volume":"38","author":"D Brandariz","year":"2017","unstructured":"Brandariz D, Smithson A, Anton-Vazquez V. Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients. Indian J Sex Transm Dis AIDS. 2017;38(2):163\u201370. https:\/\/doi.org\/10.4103\/ijstd.IJSTD_70_17.","journal-title":"Indian J Sex Transm Dis AIDS."},{"key":"416_CR176","doi-asserted-by":"publisher","first-page":"6431694","DOI":"10.1155\/2018\/6431694","volume":"2018","author":"CB Chen","year":"2018","unstructured":"Chen CB, Abe R, Pan RY, Wang CW, Hung SI, Tsai YG, et al. An updated review of the molecular mechanisms in drug hypersensitivity. J Immunol Res. 2018;2018:6431694. https:\/\/doi.org\/10.1155\/2018\/6431694.","journal-title":"J Immunol Res."},{"key":"416_CR177","volume-title":"Litt\u2019s drug eruption and reaction manual","author":"F Chan","year":"2018","unstructured":"Chan FL, Shear HN, Dodiuk-Gad R. Recommendations from various sources regarding genetic screening to prevent cutaneous adverse durg reactions. In: Shear N.H editor. Litt\u2019s drug eruption and reaction manual. 25th ed. USA: CRC Press; 2019. in press","edition":"25"},{"issue":"11","key":"416_CR178","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/j.1365-4632.2008.03827.x","volume":"47","author":"AT Mansur","year":"2008","unstructured":"Mansur AT, Pekcan Yasar S, Goktay F. Anticonvulsant hypersensitivity syndrome: clinical and laboratory features. Int J Dermatol. 2008;47(11):1184\u20139. https:\/\/doi.org\/10.1111\/j.1365-4632.2008.03827.x.","journal-title":"Int J Dermatol"},{"issue":"2","key":"416_CR179","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaad.2009.08.050","volume":"63","author":"CC Ang","year":"2010","unstructured":"Ang CC, Wang YS, Yoosuff EL, Tay YK. Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients. J Am Acad Dermatol. 2010;63(2):219\u201327. https:\/\/doi.org\/10.1016\/j.jaad.2009.08.050.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"416_CR180","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/ijd.12331","volume":"54","author":"SJ Sultan","year":"2015","unstructured":"Sultan SJ, Sameem F, Ashraf M. Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients. Int J Dermatol. 2015;54(5):537\u201342. https:\/\/doi.org\/10.1111\/ijd.12331.","journal-title":"Int J Dermatol"},{"issue":"8","key":"416_CR181","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/ced.12682","volume":"40","author":"J Avancini","year":"2015","unstructured":"Avancini J, Maragno L, Santi CG, Criado PR. Drug reaction with eosinophilia and systemic symptoms\/drug-induced hypersensitivity syndrome: clinical features of 27 patients. Clin Exp Dermatol. 2015;40(8):851\u20139. https:\/\/doi.org\/10.1111\/ced.12682.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"416_CR182","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3904\/kjim.2015.30.4.521","volume":"30","author":"HK Min","year":"2015","unstructured":"Min HK, Lee B, Kwok SK, Ju JH, Kim WU, Park YM, et al. Allopurinol hypersensitivity syndrome in patients with hematological malignancies: characteristics and clinical outcomes. Korean J Intern Med. 2015;30(4):521\u201330. https:\/\/doi.org\/10.3904\/kjim.2015.30.4.521.","journal-title":"Korean J Intern Med"},{"issue":"9","key":"416_CR183","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/ijd.13667","volume":"56","author":"JY Lee","year":"2017","unstructured":"Lee JY, Lee SY, Hahm JE, Ha JW, Kim CW, Kim SS. Clinical features of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a study of 25 patients in Korea. Int J Dermatol. 2017;56(9):944\u201351. https:\/\/doi.org\/10.1111\/ijd.13667.","journal-title":"Int J Dermatol"},{"issue":"1","key":"416_CR184","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1590\/abd1806-4841.20175190","volume":"92","author":"JM Matta","year":"2017","unstructured":"Matta JM, Flores SM, Cherit JD. Drug reaction with eosinophilia and systemic symptoms (DRESS) and its relation with autoimmunity in a reference center in Mexico. An Bras Dermatol. 2017;92(1):30\u20133. https:\/\/doi.org\/10.1590\/abd1806-4841.20175190.","journal-title":"An Bras Dermatol."},{"issue":"8","key":"416_CR185","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1097\/TP.0000000000001655","volume":"101","author":"P Ichai","year":"2017","unstructured":"Ichai P, Laurent-Bellue A, Saliba F, Moreau D, Besch C, Francoz C, et al. Acute liver failure\/injury related to drug reaction with eosinophilia and systemic symptoms: outcomes and prognostic factors. Transplantation. 2017;101(8):1830\u20137. https:\/\/doi.org\/10.1097\/tp.0000000000001655.","journal-title":"Transplantation"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-018-00416-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-00416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-018-00416-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T00:29:14Z","timestamp":1720916954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-018-00416-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":185,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,1]]}},"alternative-id":["416"],"URL":"https:\/\/doi.org\/10.1007\/s40257-018-00416-4","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]},"assertion":[{"value":"17 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No funding was received for the preparation of this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"S.A. Martinez-Cabriales, F. Rodriguez-Bola\u00f1os, and N.F. Shear declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}